Literature DB >> 19188189

Ethical responsibility of phase 0 trials.

Roberto Jun Arai, Paulo Marcelo Gehm Hoff, Gilberto de Castro, Arnold Stern.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19188189      PMCID： PMC2957892          DOI： 10.1158/1078-0432.CCR-08-1824

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  What's the price of a research subject? Approaches to payment for research participation.

Authors:  N Dickert; C Grady
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

Review 2.  Compressing drug development timelines in oncology using phase '0' trials.

Authors:  Shivaani Kummar; Robert Kinders; Larry Rubinstein; Ralph E Parchment; Anthony J Murgo; Jerry Collins; Oxana Pickeral; Jennifer Low; Seth M Steinberg; Martin Gutierrez; Sherry Yang; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James H Doroshow
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

Review 3.  Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.

Authors:  Robert Kinders; Ralph E Parchment; Jay Ji; Shivaani Kummar; Anthony J Murgo; Martin Gutierrez; Jerry Collins; Larry Rubinstein; Oxana Pickeral; Seth M Steinberg; Sherry Yang; Melinda Hollingshead; Alice Chen; Lee Helman; Robert Wiltrout; Mel Simpson; Joseph E Tomaszewski; James H Doroshow
Journal:  Mol Interv       Date:  2007-12
  3 in total
  1 in total

1.  Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.

Authors:  Roberto Jun Arai; Rodrigo Santa Cruz Guindalini; Andrea Sabina Llera; Juan Manoel O'Connor; Bettina Muller; Mauricio Lema; Helano C Freitas; Tannia Soria; Lucía Delgado; Denis Landaverde; Paola Montenegro; Rachel P Riechelmann
Journal:  Oncologist       Date:  2019-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.